Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04519723 · ClinicalTrials.gov registry record · NA
Laser 360iQ: Optimal Light-laser Combination Therapy
A NA study, sponsored by Alma Lasers.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT04519723: Completed NA study, sponsored by Alma Lasers.
NCT04519723 is a NA study that has completed, run by Alma Lasers. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04519723, a NA study, has completed, sponsored by Alma Lasers.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
To assess the safety and efficacy of light-laser combination therapy for the improvement of skin color, tone, texture and laxity
Primary Outcome
The investigator will evaluate the clinical improvement from the visual appearance of the treated area and from the fixed magnification clinical photographs according to the following Global Assessment scale (compared to baseline photographs): Global Aesthetic Improvement Scale (GAIS ) Rating Description 1. = Very much improved 75%-99% 2. = Much improved 50%-75% 3= Improved 25%-50% 4= No change 1%-25% 5=Worse \<1%
Interventions
- DEVICE Assess the safety and efficacy of light-laser therapy using the Harmony XL and Dye-VL (500-600nm), Q-Switched 1064nm, Er:YAG 2940nm modules in combination .
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-02 |
| Est. Completion | 2014-06 |
| Phase | NA |
What the finished NCT04519723 record still lists
NCT04519723 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Assess the safety and efficacy of light-laser therapy using the Harmony XL and Dye-VL (500-600nm), Q-Switched 1064nm, Er:YAG 2940nm modules in combination . is the first listed.
NCT04519723 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04519723 about?
NCT04519723 is a clinical study titled "Laser 360iQ: Optimal Light-laser Combination Therapy". To assess the safety and efficacy of light-laser combination therapy for the improvement of skin color, tone, texture and laxity
What is the current status of trial NCT04519723?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2013-02. Estimated completion is 2014-06.
What interventions are being tested in trial NCT04519723?
The interventions under investigation include: Assess the safety and efficacy of light-laser therapy using the Harmony XL and Dye-VL (500-600nm), Q-Switched 1064nm, Er:YAG 2940nm modules in combination . (DEVICE).
Who is sponsoring clinical trial NCT04519723?
This trial is sponsored by Alma Lasers, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04519723's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia